title: Macrolactam immunomodulators (tacrolimus and pimecrolimus): new horizons in the topical treatment of inflammatory skin diseases.
abstract: Tacrolimus and pimecrolimus are new macrolactam immunomodulators which were developed for the treatment of inflammatory skin diseases, mainly atopic dermatitis. In this article, we review the pharmacologic properties of the drugs, their side effects, and their clinical uses.
authors.affiliation: Department of Dermatology, Soroka Medical Center, Ben Gurion University, Beer-Sheva, Israel.
authors.forename: Marcelo H
authors.initials: MH
authors.lastname: Grunwald
authors.forename: Dan
authors.initials: D
authors.lastname: Ben Amitai
authors.forename: Boaz
authors.initials: B
authors.lastname: Amichai
mesh_terms: D000279:Administration, Cutaneous; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016559:Tacrolimus / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*
chemical_list: D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; C117268:pimecrolimus; D016559:Tacrolimus